DISCOVER
CORPORATE NEWS
2021 -PR acquisition of the Belgian eCRO Lambda-Plus -PR VisionHM listed at UniHA 2022 - PR acquisition of the Swiss company DAPSYS - PR BSA AIR - PR new facilities in Laval, France - PR new facilities in Liège, Belgium - PR FY2022 results 2023 - PR VisionHM listed at UGAP - PR acquisition of the French start-up CTMA - PR FY2023 Q1 results
Contact
Investors relation
OUR STORY,
OUR STRENGTH
Telemedicine Technologies is the publisher of e-Health solutions, market leader in the field of Clinical Research with its CleanWeb™ solution, a secure Internet platform dedicated to the electronic management of clinical trials and registries.
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
2 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
August 29, 2023
19-20 February EUCROF24 will bring together pharma, biotech, medical device companies, CROs and other service providers, technology providers, regulators, patients, and academia, to discuss the current challenges, and future direction of Clinical Research across Europe. EUCROF24 is the 7th running of the EUCROF Clinical Research Conference that attracts a diverse range of speakers and attendees from functions including clinical operations, regulatory, data […]
August 29, 2023
Workshop Topic Essentials of Paediatric Clinical Research – What you need to know when preparing, conducting and monitoring paediatric clinical trials Workshop Date & Time and Venue 12 September 2023 from 08:00 AM to 04:30 PM (CEST) Bambino Gesù Paediatric Hospital, Sede San Paolo Viale Ferdinando Baldelli, 38 Rome, Italy Training Objective Give an overview […]
August 29, 2023
Biopharmadive Although diseases such as Ehlers-Danlos syndrome, Sanfilippo syndrome and Hemophilia are considered rare, their impact looms large. Rare diseases, defined as occurring in fewer than one in 2,000 individuals, affect more than 300 million people across the globe, and most have considerable unmet medical needs. The need for more research into rare diseases is clear, but researchers face significant challenges, […]